From: Emergent pancreatectomy for neoplastic disease: outcomes analysis of 534 ACS-NSQIP patients
Demographics | All (n = 534) | PD (n = 409) | DP (n = 115) | TP (n = 10) | p-value (across groups) | p-value (DP vs. PD) |
---|---|---|---|---|---|---|
Male, no. (%) | 260 (48.7) | 196 (47.9) | 58 (50.4) | 6 (60.0) | 0.69 | 0.63 |
Age, yrs., median | 66 | 68 | 60 | 67 | < 0.001 | < 0.001 |
BMI, median | 26.5 | 26.4 | 26.8 | 22.9 | 0.22 | 0.79 |
Preoperative bili, median mg/dL | 1 | 1.5 | 0.5 | 1.8 | < 0.001 | < 0.001 |
Preoperative sepsis, no. (%) | 353 (66.4) | 288 (70.8) | 57 (49.6) | 8 (80.0%) | < 0.001 | < 0.001 |
> 4 units PRBC in 72 h before surgery (2005–2012), no. (%) | 72 (17.9) | 53 (17.2) | 18 (20.7) | 1 (12.5) | 0.7 | 0.43 |
> 10% loss body weight in last 6 months, no. (%) | 118 (22.1) | 98 (24.0) | 16 (13.9) | 4 (40.0) | 0.028 | 0.021 |
Functional status, no. (%) | 0.095 | 0.58 | ||||
Independent | 483 (91.0) | 369 (90.7) | 107 (93.9) | 7 (70.0) | ||
Partially dependent | 37 (7.0) | 28 (6.9) | 6 (5.3) | 3 (30.0) | ||
Totally dependent | 11 (2.1) | 10 (2.5) | 1 (0.9) | 0 (0.0) | ||
Chemo/Radiotherapy in ≤30 days pre-op, no. (%) | 17 (4.7) | 12 (4.2) | 3 (4.2) | 2 (25.0) | 1 | 1 |